🔎 Trials Near Me

Home › Cervical Cancer

Cervical Cancer clinical trials recruiting in the U.S.

114 studies for Cervical Cancer are recruiting participants at sites across the United States.

Cervical cancer starts in the cells of the cervix, which is the lower, narrow end of the uterus. Long-lasting HPV infection causes almost all cervical cancers.

Cities with the most studies

By state

Recently updated studies

Distance-Based Exercise to Preserve Function and Prevent Disability

Recruiting
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07059884

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06465069

Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies

RecruitingPhase 1
Ages 18 and older · Women · Updated Oct 1, 2026 · NCT07292818

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06172478

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07189871

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

RecruitingObservational study
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT05051722

DESTINY-PANTUMOUR04

RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

RecruitingPhase 4
Ages 18 and older · Women · Updated Sep 25, 2026 · NCT06952660

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07229313

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06047379

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

RecruitingPhase 1/2
Ages 18 to 99 · All sexes · Updated Sep 22, 2026 · NCT06814496

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05983432

A Study of Ivonescimab in People With Endometrial and Cervical Cancers

RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 21, 2026 · NCT06925724

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07109726

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 17, 2026 · NCT05758688

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT05475171

Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix

RecruitingObservational study
All ages · All sexes · Updated Sep 14, 2026 · NCT04723095

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT04977453

Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 10, 2026 · NCT04865887

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06293898

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.